Ömer COŞKUN, Ümit SAVAŞCI

Hepatit c virüs enfeksiyonunun patogenezi ve doğal seyri

Hepatit C Virüs (HCV) enfeksiyonunun kronikleşmesi, Siroz ve Hepatosellüler karsinoma (HCC) arasında güçlü bir bağlantı olduğu gösterilmiştir. Hepatit C virüs enfeksiyonunun doğal seyrinin tam olarak çözülebilmesi önem taşımaktadır. Bu durum uzun dönemde klinisyenlerin HCV ile ilişkili hastalıklar nedeniyle oluşabilecek komplikasyonları ve buna bağlı gelişebilecek mortalite morbiditeleri önlemede yardımcı olacaktır.

Pathogenesis and natural history of hepatitis c virus ınfection

Hepatitis C virus (HCV) infection chronicity, cirrhosis and hepatocellular carcinoma (HCC) was shown to be a strong link between. Fully solve the natural history of HCV infection is important. This situation may occur due to diseases associated with long-term complications of HCV clinicians may develop due to mortality and morbidity will help eliminate it.

PDF

___

1. Chen SL, Morgan TR. The Natural History of Hepatitis C Virus HCV Infection. International Journal of Medical Sciences. 2006; 32: 47-52.
2. Organization WH. Hepatitis C. Factsheet No 164 updated Oct 2000 www.who.int/mediacentre/factsheets. [Erişim Tarihi: 3.02.2006].
3. Moradpour D, Cerny A, Heim M. H, Blum H. E. Hepatitis C: an update. Swiss Med Wkly. 2001; 131: 291-298.
4. Coskun O, Erdem H, Besirbellioglu BA, Eyigun CP. Distribution of hepatitis C virus infection in the male Turkish population. International Journal of Infectious Diseases. 2006; 106: 481.
5. Szabo E, Lotz G, Paska C, Kiss A, Schaff Z. Viral Hepatitis: New Data on Hepatitis C. Infection. Pathology Oncology Resarch. 2003; 9(4), 215-221
6. Neumann AU. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998; 282: 103-107.
7. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 332: 1463-1466.
8. Bertoletti A, Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003; 38: 4-13.
9. Cãruntu F. A, Benea L. Acute Hepatitis C Virus Infection: Diagnosis, Pathogenesis, Treatment. J Gastrointestin Liver Dis. 2006; 153: 249-256.
10. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 2005; 5: 215-229.
11. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis. 2005; 25: 7-17.
12. Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002; 365: 21-29.
13. Sarobe P, Lasarte JJ, Garcia N. Characterization of T- cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins. J Viral Hepat. 2006: 13: 47-55.
14. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis. 2004; 242: 3-8.
15. Orland JR, Wright TL, Cooper S. Acute hepatitis C. Hepatology. 2001; 33: 321-327.
16. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 1992; 258: 135-140.
17. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 1994; 343: 388-390.
18. Lechner F, Wong DK, Dunbar PR, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000; 191: 1499-1512.
19. Diepolder HM, Zachoval R, Hoffmann RM, et al. Possible mechanism involving T lymphocyte response to non structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995; 346: 1006-1007.
20. Missale G, Bertoni R, Lamonaca V, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cellmediated immune response. J Clin Invest. 1996; 98: 706-714.
21. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 1999; 30: 595-601.
22. Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 3418: 556-562.
23. Sümbül M. HCV infeksiyonunun epidemiyolojisi ve korunma. Eds.: Tabak F, Balık İ, Tekeli E. In: Viral Hepatit. İstanbul. Viral hepatit Savaşım Derneği, 2007, s. 203-215.
24. Farci P. Hepatitis C virus-associated fulminant hepatic failure N Engl J Med. 1996; 3359: 631-634.
25. Yenen OŞ. Akut viral hepatitler. Eds.: Topçu AW, Söyletir G, Doğanay M. In: İnfeksiyon Hastalıkları ve Mikrobiyolojisi. İstanbul. Nobel tıp kitabevleri, 2002, s. 820-835.
26. Pawlotsky JM. Use and interpretation of virological tests for hepatitis. Hepatology. 2002; 36(5): 65-73.
27. Lavillette D, Morice Y, Germanidis G. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol. 2005; 79: 6023-6034.
28. Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol. 2001; 354: 531-537.
29. Vogt M. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med. 1999; 34112: 866-870.
30. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999; 34016: 1228-1233.
31. Wiese M. Low frequency of cirrhosis in a hepatitis C genotype1b single-source outbreak in germany: a 20-year multicenter study. Hepatology. 2000; 321: 91-96.
32. Villano SA. Persistence of viremia and the importance of longterm follow-up after acute hepatitis C infection. Hepatology. 1999; 293: 908-914.
33. Howell C, Jeffers L, Hoofnagle JH. Hepatitis C in African Americans: summary of a workshop. Gastroenterology. 2000; 1195: 1385-1396.
34. Nguyen MH, Whittemore AS, Garcia RT. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol. 2004; 29: 820-824.
35. Lechner F. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000; 1919: 1499-1512.
36. Thomas DL. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000; 2844: 450-456.
37. Fattovich G. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997; 1122: 463-472.
38. Donato F, Boffetta P, Puoti MA. Meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma Int J Cancer. 1998; 753: 347-354.
39. Ikeda K, Saıtoh S, Arase Y, et al. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology. 1999; 294: 1124-1130.
40. Tong M.J, el-Farra NS, Reikes AR. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995; 33222: 1463-1466.
41. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic Manifestations of Chronic HCV Infection. J Gastrointestin Liver Dis. 2007; 161: 65-73.
42. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus in type II cryoglobulinemia. N Engl J Med. 1992; 327: 1490-1495.
43. Misiani R, Bellavita P, Fenili D, et al. Hepatitis C infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992; 117: 573-577.
44. Pawlotsky JM, Roudot-Thoraval F, Simmonds P. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med. 1995; 122: 169-173.
45. Zignego Al, Giannelli F, Marocchi ME. T 14;18 translocation in chronic hepatitis C virus infection. Hepatology. 2000; 31: 474-479.
46. De Vita S, De Re V, Sansonno D. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and chronic gastritis. Hepatology. 2000; 31: 182-189.
47. Tursi A, Brandimante G, Chiarelli F SA, Torello M. Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma. Am J Gastroenterol. 2002; 97: 1802-1806.
48. Fargion S, Piperno A, MD C, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992; 16: 1322-1326.
49. Carrozzo M, Gandolfo S, Carbone M. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med. 1996; 25: 527-533.
50. Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study. Clin Endocrinol Oxf. 1999; 50: 503-509.
51. Antonelli A, Ferri C, Pampana A. Thyroid disorders in chronic hepatitis C. Am J Med. 2004; 117: 10-13.
52. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA. 1999; 281: 1588.
53. Haddad J, Deny P, Munz-Gotheil C. Lymphocytic sialadenitis of Sjogren’s syndrome associated with chronic hepatitis C virus liver disease. Lancet. 1992; 339: 321-323.